GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Love Hemp Group PLC (AQSE:LIFE) » Definitions » Risk Assessment

Love Hemp Group (AQSE:LIFE) Risk Assessment


View and export this data going back to 2019. Start your Free Trial

What is Love Hemp Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Love Hemp Group is: No Data: Cannot be evaluated.


Competitive Comparison of Love Hemp Group's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Love Hemp Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Love Hemp Group's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Love Hemp Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Love Hemp Group's Risk Assessment falls into.



Love Hemp Group  (AQSE:LIFE) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Love Hemp Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of Love Hemp Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Love Hemp Group (AQSE:LIFE) Business Description

Traded in Other Exchanges
N/A
Address
15 Ingestre Place, Suite 1, London, GBR, W1F 0DU
Love Hemp Group PLC is a Cannabidiol and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products.

Love Hemp Group (AQSE:LIFE) Headlines

From GuruFocus

aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment

By Value_Insider Value_Insider 12-15-2022

aTyr Pharma to Present at Upcoming Investor Conferences

By Value_Insider Value_Insider 11-10-2022